Watson Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LABS INC, and what generic and branded alternatives to WATSON LABS INC drugs are available?
WATSON LABS INC has seventy-five approved drugs.
There are eleven tentative approvals on WATSON LABS INC drugs.
Drugs and US Patents for Watson Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs Inc | CELECOXIB | celecoxib | CAPSULE;ORAL | 200562-001 | Feb 11, 2015 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Watson Labs Inc | EZETIMIBE | ezetimibe | TABLET;ORAL | 200831-001 | Jun 12, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Watson Labs Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062994-001 | Sep 15, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Watson Labs Inc | CEFUROXIME SODIUM | cefuroxime sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 064035-001 | Feb 26, 1993 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Watson Labs Inc | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | JELLY;TOPICAL | 040837-001 | Mar 23, 2011 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Watson Labs Inc | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 062844-005 | Oct 26, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.